Gatti M.; Andreoni M.; Pea F.; Viale P., Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: A careful appraisal beyond approved indications focusing on unmet clinical needs, «DRUG DESIGN, DEVELOPMENT AND THERAPY», 2021, 15, pp. 3349 - 3378 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections?, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 403 - 407 [Scientific article]
Gaibani, Paolo; Gatti, Milo; Rinaldi, Matteo; Crovara, Cristina; Lazzarotto, Tiziana; Giannella, Maddalena; Lombardo, Donatella; Amadesi, Stefano; Viale, Pierluigi; Pea, Federico; Ambretti, Simone, Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient, «INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES», 2021, 113, pp. 213 - 217 [Scientific article]Open Access
Wagenlehner, Florian; Lucenteforte, Ersilia; Pea, Federico; Soriano, Alex; Tavoschi, Lara; Steele, Victoria R; Henriksen, Anne Santerre; Longshaw, Christopher; Manissero, Davide; Pecini, Raymond; Pogue, Jason M, Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins, «CLINICAL MICROBIOLOGY AND INFECTION», 2021, 27, pp. 671 - 686 [Scientific article]Open Access
Andreoni M.; Bassetti M.; Corrao S.; De Rosa F.G.; Esposito V.; Falcone M.; Grossi P.; Pea F.; Petrosillo N.; Tascini C.; Venditti M.; Viale P., The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, 19, pp. 1125 - 1134 [Scientific article]
Sartelli M.; Ansaloni L.; Bartoletti M.; Catena F.; Cardi M.; Cortese F.; Di Marzo F.; Pea F.; Plebani M.; Rossolini G.M.; Sganga G.; Viaggi B.; Viale P., The role of procalcitonin in reducing antibiotics across the surgical pathway, «WORLD JOURNAL OF EMERGENCY SURGERY», 2021, 16, Article number: 15 , pp. 1 - 9 [Scientific article]Open Access
Cojutti P.G.; Rinaldi M.; Gatti M.; Tedeschi S.; Viale P.; Pea F., Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2021, 58, Article number: 106445 , pp. 1 - 3 [Scientific article]
Barco S.; Mesini A.; Barbagallo L.; Maffia A.; Tripodi G.; Pea F.; Saffioti C.; Castagnola E.; Cangemi G., A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients, «JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS», 2020, 186, Article number: 113273 , pp. 1 - 10 [Scientific article]
Sganga G.; Pea F.; Aloj D.; Corcione S.; Pierangeli M.; Stefani S.; Rossolini G.M.; Menichetti F., Acute wound infections management: the ‘Don’ts’ from a multidisciplinary expert panel, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2020, 18, pp. 231 - 240 [Scientific article]
Bassetti M.; Vena A.; Bouza E.; Peghin M.; Munoz P.; Righi E.; Pea F.; Lackner M.; Lass-Florl C., Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?, «CLINICAL MICROBIOLOGY AND INFECTION», 2020, 26, pp. 1024 - 1033 [Scientific article]
Abdul-Aziz M.H.; Alffenaar J.-W.C.; Bassetti M.; Bracht H.; Dimopoulos G.; Marriott D.; Neely M.N.; Paiva J.-A.; Pea F.; Sjovall F.; Timsit J.F.; Udy A.A.; Wicha S.G.; Zeitlinger M.; De Waele J.J.; Roberts J.A., Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#, «INTENSIVE CARE MEDICINE», 2020, 46, pp. 1127 - 1153 [Scientific article]
Cattani G.; Madia A.; Arnoldo L.; Brunelli L.; Celotto D.; Grillone L.; Valent F.; Castriotta L.; Pea F.; Bassetti M.; Brusaferro S., Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital, «ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITÀ», 2020, 32, pp. 344 - 356 [Scientific article]
Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 1251 - 1260 [Scientific article]Open Access
Giacobbe, Daniele Roberto; Ciacco, Eugenio; Girmenia, Corrado; Pea, Federico; Rossolini, Gian Maria; Sotgiu, Giovanni; Tascini, Carlo; Tumbarello, Mario; Viale, Pierluigi; Bassetti, Matteo, Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data, «INFECTION AND DRUG RESISTANCE», 2020, Volume 13, pp. 4697 - 4711 [Scientific article]Open Access
Pea F., From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis, «MYCOSES», 2020, 63, pp. 854 - 858 [Scientific article]
